646 related articles for article (PubMed ID: 10343000)
1. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
Mahinka SP; Sanzo KM
Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
[No Abstract] [Full Text] [Related]
2. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
Whitener MD
Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
[No Abstract] [Full Text] [Related]
3. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
Reichertz PS
Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
[No Abstract] [Full Text] [Related]
4. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
Zain S
Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
[No Abstract] [Full Text] [Related]
5. Claim substantiation in the health care industry.
Fergenson PE
Hosp Mater Manage Q; 1992 May; 13(4):20-6. PubMed ID: 10117377
[No Abstract] [Full Text] [Related]
6. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
Allen MC
Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
[No Abstract] [Full Text] [Related]
7. The role of the Federal Trade Commission in advertising health products and services.
Daynard M
J Am Coll Dent; 2004; 71(2):24-6. PubMed ID: 15347100
[TBL] [Abstract][Full Text] [Related]
8. Antitrust enforcement in pharmaceutical industry mergers.
Balto DA; Mongoven JF
Food Drug Law J; 1999; 54(3):255-78. PubMed ID: 11797700
[No Abstract] [Full Text] [Related]
9. Prescription drug advertising--should states regulate what is false and misleading?
Shaeffer J
Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
[No Abstract] [Full Text] [Related]
10. Market power, collusion, and exclusion in health care antitrust enforcement.
Spears JM
J Med Assoc Ga; 1992 Sep; 81(9):499-507. PubMed ID: 1402429
[No Abstract] [Full Text] [Related]
11. Major issues in marketing regulation.
Pines WL
Food Drug Law J; 1997; 52(3):297-302. PubMed ID: 10343028
[No Abstract] [Full Text] [Related]
12. Regulation of health services advertising.
Barney DR
Hosp Health Serv Adm; 1983; 28(3):85-110. PubMed ID: 10299216
[No Abstract] [Full Text] [Related]
13. Legal guidelines to health services marketing: issues & checklists.
Berning RK
J Health Care Mark; 1983; 3(2):47-9. PubMed ID: 10261799
[No Abstract] [Full Text] [Related]
14. The new drug marketing: a consumer protection perspective.
Woodward D
Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
[No Abstract] [Full Text] [Related]
15. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Javitt GH; Stanley E; Hudson K
Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
[No Abstract] [Full Text] [Related]
16. FTC regulation of health care advertising: when providers deceive.
Buc NL; Hofkin LA
Healthspan; 1992 Oct; 9(9):3-6. PubMed ID: 10122717
[No Abstract] [Full Text] [Related]
17. Healthcare advertising: what you can and cannot say.
Barney DR
Healthspan; 1985 Jan; 2(1):3-10. PubMed ID: 10271480
[No Abstract] [Full Text] [Related]
18. Federal Trade Commission antitrust enforcement in the dental profession.
Ragan MR
J Law Ethics Dent; 1990; 3():5-11. PubMed ID: 2098529
[No Abstract] [Full Text] [Related]
19. Antitrust warning. Court: dental association's advertising limits restrict trade.
Japsen B
Mod Healthc; 1997 Nov; 27(44):16. PubMed ID: 10174142
[No Abstract] [Full Text] [Related]
20. A global view of the First Amendment constraints of FDA.
Carver KH
Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
